Live Breaking News & Updates on Uture Developments Ora Change In Expectations Or Assumptions The Telix Pharmaceuticals And Illuccix Name Logo Are Trademarks Of Limited Its Affiliates All Rights Reserved 1 Asx Disclosure 20 December 2021 2 November 3 14 October 2022

Stay updated with breaking news from Uture developments ora change in expectations or assumptions the telix pharmaceuticals and illuccix name logo are trademarks of limited its affiliates all rights reserved 1 asx disclosure 20 december 2021 2 november 3 14 october 2022 . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Telix Acquires Optimal Tracers

MELBOURNE, Australiaand INDIANAPOLIS, Ind., Nov. 14, 2022 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)today announces that it has entered into an agreement with Sacramento-based Northern California PET Imaging Center (NCPIC) to acquire Optimal Tracers, a radiochemistry development business providing radiochemistry process development services and research tracers for use in clinical trials. The acquisition of Optimal Tracers will bolster Telix's in-house radiochemistry development capability, by adding a highly skilled team to Telix and establishing a U.S.-based laboratory and production footprint for clinical trial doses. The acquisition includes a facilitywith a radiation and pharmaceutical manufacturing licence sufficient to cover the Company's key diagnostic and therapeutic isotope requirements for pre-clinical and clinical research purposes. The acquisition of Optimal Tracers aligns with Telix's strategy to build a degree of vertical inte ....

United States , United Kingdom , Kyahn Williamson , Jonathan Barlow , Ruth Tesar , University Of California , Telix Pharmaceuticals , Drug Administration , Australian Securities Exchange , Prnewswire Telix Pharmaceuticals Limited , Australian Therapeutic Goods Administration , Imaging Center , Corporate Communications , Global Business Development Alliance Management , Health Canada , Pharmaceuticals Limited , Sacramento Based Northern California , Optimal Tracers , West Coast , Business Development , Alliance Management , Optimal Tracer , Northern California , Telix Pharmaceuticals Limited , Ustraliaand Indianapolis , Nov 14 ,

Telix Acquires Optimal Tracers

MELBOURNE, Australiaand INDIANAPOLIS, Ind., Nov. 14, 2022 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)today announces that it has entered into an agreement with Sacramento-based Northern California PET Imaging Center (NCPIC) to acquire Optimal Tracers, a radiochemistry development business providing radiochemistry process development services and research tracers for use in clinical trials. The acquisition of Optimal Tracers will bolster Telix's in-house radiochemistry development capability, by adding a highly skilled team to Telix and establishing a U.S.-based laboratory and production footprint for clinical trial doses. The acquisition includes a facilitywith a radiation and pharmaceutical manufacturing licence sufficient to cover the Company's key diagnostic and therapeutic isotope requirements for pre-clinical and clinical research purposes. The acquisition of Optimal Tracers aligns with Telix's strategy to build a degree of vertical inte ....

United States , United Kingdom , Kyahn Williamson , Jonathan Barlow , Ruth Tesar , University Of California , Telix Pharmaceuticals , Drug Administration , Australian Securities Exchange , Prnewswire Telix Pharmaceuticals Limited , Australian Therapeutic Goods Administration , Imaging Center , Corporate Communications , Global Business Development Alliance Management , Health Canada , Pharmaceuticals Limited , Sacramento Based Northern California , Optimal Tracers , West Coast , Business Development , Alliance Management , Optimal Tracer , Northern California , Telix Pharmaceuticals Limited , Ustraliaand Indianapolis , Nov 14 ,